Yoon Sam-Youl, Kim Ki-Hun, Jung Dong-Hwan, Yu Ami, Lee Sung-Gyu
Department of Surgery, Korea University Ansan Medical Center, Korea University College of Medicine, Gyeonggi-do, Korea,
Surg Endosc. 2015 Sep;29(9):2628-34. doi: 10.1007/s00464-014-3980-1. Epub 2014 Dec 9.
The purpose of this study is the evaluation of the surgical and oncological results of laparoscopic liver resection (LLR) for hepatocellular carcinoma (HCC) by comparing laparoscopic and open liver resection (OLR) in the treatment of this disease. Retrospective analysis of laparoscopic and OLR for HCC (<5 cm) performed over a 4-year period was conducted. The LLR was done by a single surgeon.
The study was performed on patients who received liver resection for HCC between July 2007 and August 2011 in our institution. Propensity-based matched analyses were used to account for operative method selection biases. During the 4 years, 1,050 patients with HCC received an operation. Among them patients who never received TACE or RFA before surgery and had HCC (<5 cm) were selected for this study.
174 patients had OLR, and 58 patients underwent LLR. Patients who received LLR had lower operative time, transfusion rate, complication rate, and shorter hospital days. There were significant differences in hospital mortality and morbidity between the two groups. Dietary recovery was relatively fast in the group of LLR. Overall and disease-free survival rates during the 4 years were also not significantly different between the two groups.
LLR is a developing and safe technique in a select group of patients including those with malignancies, and use of this procedure is associated with short hospital stays, a rapid return to a normal diet, full mobility, and minimal morbidity, with acceptable oncological parameters. It may be an optimal method of hepatectomy in HCC (<5 cm). Further, long-term follow-up should be acquired for adequate evaluation for survival.
本研究的目的是通过比较腹腔镜肝切除术(LLR)和开腹肝切除术(OLR)治疗肝细胞癌(HCC)的手术及肿瘤学结果,来评估LLR治疗HCC的效果。对4年间进行的HCC(<5 cm)的腹腔镜和OLR手术进行回顾性分析。LLR手术由同一位外科医生完成。
本研究对2007年7月至2011年8月在我院接受HCC肝切除术的患者进行。采用倾向匹配分析来处理手术方法选择偏倚。在这4年中,1050例HCC患者接受了手术。其中,选择术前未接受过经动脉化疗栓塞术(TACE)或射频消融术(RFA)且HCC(<5 cm)的患者纳入本研究。
174例患者接受了OLR,58例患者接受了LLR。接受LLR的患者手术时间更短、输血率更低、并发症发生率更低且住院天数更短。两组在医院死亡率和发病率方面存在显著差异。LLR组的饮食恢复相对较快。两组在4年期间的总生存率和无病生存率也无显著差异。
LLR在包括恶性肿瘤患者在内的特定患者群体中是一种不断发展且安全的技术,采用该手术与住院时间短、快速恢复正常饮食、完全恢复活动能力以及最低发病率相关,肿瘤学参数可接受。它可能是HCC(<5 cm)肝切除术中的一种最佳方法。此外,应进行长期随访以充分评估生存率。